The evaluation of adverse drug reactions in Saudi Arabia: A retrospective observational study.

Alenzi, Khalidah A; Alanazi, Najah S; Almalki, Mohammed; Alomrani, Homoud; Alatawi, Fahad O

Alenzi, Khalidah A; Alanazi, Najah S; Almalki, Mohammed; Alomrani, Homoud; Alatawi, Fahad O.

Afiliación

Alenzi KA; Ministry of Health, Regional Drug Information & Pharmacovigilance Center, Tabuk, Saudi Arabia.
Alanazi NS; Pharm D, University of Tabuk, Tabuk, Saudi Arabia.
Almalki M; Ministry of Health, Umlog Hospital, Tabuk, Saudi Arabia.
Alomrani H; Ministry of Health, Haqel Hospital, Tabuk, Saudi Arabia.
Alatawi FO; Ministry of Health, King Fahad Specialist Hospital, Tabuk, Saudi Arabia.

Saudi Pharm J ; 30(6): 735-741, 2022 Jun.

Article en En | MEDLINE | ID: mdl-35812140

Palabras clave

ADR, Adverse drug reaction; Adverse drug reactions; KSA, The Kingdom of Saudi Arabia; MOH, The Saudi Ministry of Health; Naranjo scale; Pharmacovigilance; RDIC, Regional Drug Information Center; SFDA, Saudi Food and Drug Authority; WHO, The World Health Organization

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Saudi Pharm J Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación:

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google